Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-07

Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) [Phase 3]

View source ↗

Summary

This completed Phase 3 study evaluated fidaxomicin (oral suspension or tablets) versus vancomycin (oral liquid or capsules) for pediatric Clostridioides diffici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fidaxomicin (fidaxomicin)
  • Vancomycin (vancomycin)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Clostridium Difficile-associated Diarrhea (CDAD) | Phase 3 | Status: COMPLETED | Results posted: 2018-12-07